A lower level of FATS expression in breast cancer was associated with a higher nuclear grade (P = .01), and there were no correlations between FATS mRNA levels and other clinicopathologic factors including clinical stage, tumor size, lymph node status, ER status and PR status. The gene discussed is ESR1; the disease is breast cancer.